Kai Lin

An adenosine nucleoside inhibitor of dengue virus

Zheng Yin, Yen‐Liang Chen, Wouter Schul et al. · Proceedings of the National Academy of Sciences · 2009 · 389 citations · Full text

Dengue Virus, Molecular Virology, Medicine +9

Preclinical Profile of VX-950, a Potent, Selective, and Orally Bioavailable Inhibitor of Hepatitis C Virus NS3-4A Serine Protease

Robert B. Perni, Susan J. Almquist, Randal A. Byrn et al. · Antimicrobial Agents and Chemotherapy · 2006 · 382 citations · Full text

In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Kai Lin, Yu-Ping Luong et al. · Journal of Biological Chemistry · 2004 · 289 citations · Full text

In Vitro Studies of Cross-resistance Mutations against Two Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

Chao Lin, Cynthia A. Gates, B. Govinda Rao et al. · Journal of Biological Chemistry · 2005 · 216 citations · Full text

Viral Hepatitis, Ns3.4a Serine Protease, Natural Sciences +14

VX-950, a Novel Hepatitis C Virus (HCV) NS3-4A Protease Inhibitor, Exhibits Potent Antiviral Activities in HCV Replicon Cells

Kai Lin, Robert B. Perni, Ann D. Kwong et al. · Antimicrobial Agents and Chemotherapy · 2006 · 200 citations · Full text

Ns3-4a Serine Protease, Molecular Virology, Hcv Replicon Cells +14